Seeking Alpha
 

Par Pharmaceutical Companies, Inc. (PRX)

- Pending
  • Jul. 16, 2012, 8:24 AM
    TPG agrees to acquire Par Pharmaceutical (PRX) for $1.9B, or $50/share, which represents a 37% premium over Par's closing price on Friday. Shares +36% premarket. (PR)
    | Jul. 16, 2012, 8:24 AM | Comment!
Visit Seeking Alpha's
PRX vs. ETF Alternatives
Company Description
Sector: Healthcare
Industry: Drugs - Generic
Country: United States